Mahashakti Ayurved Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 06-07-2024
- Paid Up Capital ₹ 1.40 M
as on 06-07-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.35 M
as on 06-07-2024
- Revenue 5.09%
(FY 2022)
- Profit -2752.00%
(FY 2022)
- Ebitda 56.51%
(FY 2022)
- Net Worth -1.38%
(FY 2022)
- Total Assets 0.29%
(FY 2022)
About Mahashakti Ayurved
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.40 M.
The company currently has active open charges totaling ₹8.35 M.
Ashish Chouhan, Manish Chouhan, and Somnath Gunjal serve as directors at the Company.
- CIN/LLPIN
U51909MP2019PTC047402
- Company No.
047402
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Hosangabad, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Mahashakti Ayurved Private Limited offer?
Mahashakti Ayurved Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Immunity Booster, Herbal Oil, Ayurvedic Herbal Syrups & Tonics, Common Disease Medicines, Herbal Cough Syrup.
Who are the key members and board of directors at Mahashakti Ayurved?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Chouhan  | Director | 04-Jan-2019 | Current |
| Manish Chouhan | Director | 04-Jan-2019 | Current |
| Somnath Gunjal | Director | 04-Jan-2019 | Current |
Financial Performance of Mahashakti Ayurved.
Mahashakti Ayurved Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 5.09% increase. The company also saw a substantial fall in profitability, with a 2752% decrease in profit. The company's net worth dipped by a decrease of 1.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mahashakti Ayurved?
In 2022, Mahashakti Ayurved had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 30 Aug 2023 | ₹4.27 M | Open |
Others Creation Date: 13 May 2022 | ₹1.08 M | Open |
Others Creation Date: 24 Feb 2021 | ₹3.00 M | Open |
How Many Employees Work at Mahashakti Ayurved?
Unlock and access historical data on people associated with Mahashakti Ayurved, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mahashakti Ayurved, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mahashakti Ayurved's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
